Clinical Evidence Supporting GLP1 MASLD MASH Treatment Several clinical trials support the use of GLP1 receptor agonists in reducing hepatic fat and improving histologic features of MASH
In 2025, KFF reported that 19% of employers with 200+ workers and 43% with 5,000+ workers covered GLP-1s for weight loss, and employers are expected to revisit coverage and cost-containment strategies each year as demand remains high
According to MEDVi's own published disclosures, compounded GLP-1s are "produced in FDA-regulated facilities" but "the medications are not FDA-approved or evaluated for safety, efficacy, or quality." Compounded GLP-1 Tablets: The company's website also lists an oral GLP-1 tablet option starting at $249 per month, described as one dissolvable tablet per day
Geographic Service Availability: According to Direct Meds website information current as of January 2026, the platform provides services to most US states but does not currently serve residents of Mississippi or Louisiana, where telehealth prescription of weight loss medications is restricted by state law
